Patient Interest and Participation in Clinical Trials: What Really Matters
Today, clinical development of new therapies – especially patient recruitment into clinical trials – has never been more challenging. It takes longer to recruit patients; trial complexity is increasing; and fewer patients are willing to volunteer,* despite the fact that most patients report interest in clinical trials. So what patient characteristics really influence interest – and more importantly, participation – in clinical research? To help answer this question, Health Union compiled data from more than 21,000 respondents across six surveys conducted in 2014 and 2015 to examine factors involved in patients’ interest and participation in clinical research. Each survey focused on gathering insights from patients with a chronic condition, such as COPD, migraine, multiple sclerosis, rheumatoid arthritis, and hepatitis C, about their disease journey, as well as its impact on quality of life and treatment experiences, including clinical trials.
Read more by downloading our free whitepaper,
“Patient Interest and Participation in Clinical Trials: What Really Matters”
*CliniPace Worldwide. (2014) Infographic – Trends in Clinical Trial Site Selection and Patient Recruitment.